コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 al propeptide, and C-terminal telopeptide of type I collagen).
2 usable vessels in a bioremodelable hydrogel (type I collagen).
3 anslation of collagen mRNAs and synthesis of type I collagen.
4 lity and in vitro proteolytic degradation of type I collagen.
5 ly349Cys substitution in the alpha1 chain of type I collagen.
6 s by secreting mesenchymal proteins, such as type I collagen.
7 nectin (FN) and block interaction of FN with type I collagen.
8 synthesis, and facilitating cell adhesion to type I collagen.
9 er GFP mice, we find that fibrocytes express type I collagen.
10 hat fibrocytes are not a necessary source of type I collagen.
11 re required for efficient internalization of type I collagen.
12 NF-alpha), RAGE, periostin, fibronectin, and type I collagen.
13 ars of age stimulates fibroblasts to produce type I collagen.
14 tin, SNAIL1, SNAIL2, and the alpha2 chain of type I collagen.
15 ion of Syk activity restored MK migration on type I collagen.
16 e the production and spatial organization of type I collagen.
17 ast tumor cell line, MDA-MB-231, embedded in type I collagen.
18 cifically inhibits their capacity to degrade type I collagen.
19 ration and reduced accumulation of fibrillar type I collagen.
20 pancreatic cancer cells in three-dimensional type I collagen.
21 matrix via the upregulation of the gene for Type I Collagen.
22 profile of 3D tissues embedded within native type I collagen.
23 d the LH3 function as glucosyltransferase in type I collagen.
24 nM concentrations of C9 reduced secretion of type I collagen.
25 cancer cell scattering in three-dimensional type I collagen.
26 ilize integrins to attach and proliferate on type I collagen.
27 is characterized by excessive production of type I collagen.
28 l fibroblasts led to increased expression of type I collagen.
29 serum beta C-terminal telopeptide (B-CTx) of type I collagen.
30 cise co-localization of CNA-35 micelles with type I collagen.
31 otype resulted in a significant reduction of type I collagen.
32 p.G736D) substitution in the alpha1 chain of type I collagen.
33 h Fam20C was inactivated in cells expressing Type I collagen.
34 FKBP19 seems to interact with triple helical type I collagen.
35 and was further increased after adhesion to type I collagen.
36 5 prefers to interact with Hsp47 rather than type I collagen.
37 nsistent with decreased proband secretion of type I collagen.
38 alities in the structure and/or synthesis of type I collagen.
39 s or solid spiky masses when plated in 3D in type-I collagen.
40 e, where little 3-hydroxylation was found in type I collagen, 3-hydroxylation of type I collagen in a
41 inary N-terminal cross-linked telopeptide of type I collagen: 48.2 +/- 2.9 compared with 38.9 +/- 0.9
44 of PDL osteoblastic differentiation markers: type I collagen, alkaline phosphatase, and osteocalcin.
45 , the multilayered cells express Osterix and Type I collagen alpha, resulting in generation of mature
46 ver, mature osteoblast-related expression of type I collagen alpha1 and osteocalcin was reduced in bo
47 pproximately 90% direct sequence coverage of type I collagen alpha1- and alpha2-chains, representing
48 chondral bone were determined by MicroCT and type I collagen alpha1/alpha2 ratio was determined by SD
50 ce/bone volume ratio, and an increase in the Type I collagen alpha1/alpha2, compared to normal-weight
51 f intron 36 of the Col1a1 gene, encoding the type I collagen, alpha1 chain, was responsible for the p
54 0 secretion increased by 90% with binding to type I collagen and 55% with fibronectin, whereas MMP-7
55 hesion to and aggregation induced by soluble type I collagen and a delayed onset to low dose fibrilla
56 gh levels of type II collagen as compared to type I collagen and absence of Mmp-9 in the cartilage of
57 Recombinant human relaxin-2 down-regulates type I collagen and alpha smooth muscle actin production
58 19b was confirmed by decreased expression of type I collagen and by blocking TGF-beta-induced express
59 gen biosynthesis, which retards secretion of type I collagen and causes excessive posttranslational m
60 rkably long half-life, matrix proteins, like type I collagen and elastin, are preferential targets.
62 em mass spectrometry) showed increased renal type I collagen and fibronectin protein abundance result
65 deposition was accelerated with upregulated type I collagen and interleukin-1beta, and downregulated
66 1), (2) significantly promoted production of type I collagen and other extracellular molecules (p < 0
67 re characterized by the expression of alpha1 type I collagen and PDGFRbeta, produce erythropoietin th
68 Channel catfish skin collagens were typical type I collagens and could have applications in food, me
69 gulation of its downstream ECM genes such as type I collagens and proteoglycans such as fibromodulin
73 CTX (C-terminal crosslinking telopeptide of type I collagen) and TRACP-5b (tartrate-resistant acid p
74 lagen type I, carboxyterminal telopeptide of type I collagen, and aminoterminal propeptide of procoll
76 scular endothelial growth factor, periostin, Type I collagen, and fibronectin were also evaluated.
77 They also exhibited increased adhesion on type I collagen, and hyperresponsive CRP and CLEC-2-indu
78 rgely suppressed expression of alpha-SMA and type I collagen, and reduced the deposition of extracell
79 rosine-phosphorylated proteins and levels of type I collagen, and scavenged ROS in SSc fibroblasts.
80 a1 integrin in contact with dermal fibrillar type I collagen, and the activity of MMP-1 is required f
81 on of alpha-smooth muscle actin (alpha-SMA), type I collagen, and VE-cadherin expression, and the exp
84 ll surface HA coat impaired cell adhesion to type I collagen, as indicated by recovery of adhesion fo
86 s suggest that amide I NLO chiral effects in type I collagen assemblies arise predominantly from the
87 ight into how LECs negotiate an interstitial type I collagen barrier and reveal an unexpected MMP2-dr
89 her levels of carboxyterminal telopeptide of type I collagen (beta=0.22, P<0.001) and aminoterminal p
90 f the alpha2beta1 integrin, one of the major type I collagen-binding receptors in mammalian cells.
91 and alphaVbeta3 blockade markedly decreased type I collagen breakdown, and impaired both monocyte ad
92 dominant bone dysplasia caused by defects in type I collagen, but in the past 10 years discoveries of
93 g growth factor beta1-mediated expression of type I collagen by inhibiting Twist, a prominent mesench
95 sidues/1000 residues) and were identified as type-I collagens by FTIR, SDS-PAGE, and molecular weight
97 e sex, high levels of bone resorption (serum type I collagen C-telopeptide), low hip bone mineral den
101 cid compositions of rat skin and tail tendon type I collagen chains indeed showed 3-4 residues of 3Hy
102 droxylation at multiple substrate sites from type I collagen chains was high in sclera, similar to te
103 del using culture plate wells connected with type I collagen-coated large bore tubing and has recircu
104 neralized tissue-associated genes, including Type I collagen (COL I), runt-related transcription fact
107 eta1, tumor necrosis factor (TNF)-alpha, and type I collagen (Col-I) expression, and promoted the pro
108 reporter protein (EGFP) under control of the type I collagen (Col-I) promoter (COL-EGFP) had green st
111 ultures of mouse hepatocytes were exposed to type I collagen (COL1); cell injury was assessed by morp
113 scence reporter downstream of the endogenous type I collagen (COL1A1) promoter in skin fibroblasts.
114 r matrix (ECM) proteins fibronectin (FN) and type I collagen (collagen I) are codistributed in many t
117 scratch wound assay, cell number count, and type I collagen contraction assay were used to examine t
118 onger detectable, but the structural protein type I collagen could be used to differentiate all four
121 P) and C-terminal crosslinked telopeptide of type I collagen (CTX) derived from matrix-metalloprotein
122 increase in serum C-terminal telopeptide of type I collagen (CTX) was completely reversed by ES.
123 bone resorption (C-terminal telopeptides of type I collagen (CTX)) and bone formation (procollagen t
124 resorption marker C-telopeptide fragments of type I collagen (CTX), elevated osteoclastogenesis, and
126 pe I procollagen (PINP) and C-telopeptide of type I collagen (CTX-I) are markers of bone formation an
128 ere most cases are due to autosomal dominant type I collagen defects, while rare, mostly recessive, f
129 findings provide a mechanistic paradigm for type I collagen degradation by MMP1 and establish a gene
130 both of which are associated with increased type I collagen density and tissue stiffness and are the
132 oposed as an important direct contributor of type I collagen deposition during fibrosis based largely
133 increased glycosylation of hydroxylysine in type I collagen disturbs the lateral growth of the fibri
135 inding sequence could lead to degradation of type I collagen, early embryonic lethality, and the scar
136 ) and Ser(203) in MFAP4 as being crucial for type I collagen, elastin, and tropoelastin binding.
139 ng with a gadolinium-based probe targeted to type I collagen (EP-3533) to image and quantify fibrosis
140 actor beta1 (TGFbeta1) induced alpha-SMA and type I collagen expression and inhibited VE-cadherin.
141 r-kappaB (NF-kappaB) transcription factor on type I collagen expression in adult normal human (ANF) a
143 -costimulated SSc lymphocytes induced higher type I collagen expression in fibroblasts, which was par
147 the cell line faithfully reports changes in type I collagen expression with at least threefold enhan
148 stimulation of alpha-smooth muscle actin and type I collagen expression, indicative of myofibroblast
152 onstrate that shortly following contact with type I collagen extracellular signal-regulated kinase (E
155 of the A3 site in both alpha-chains, whereas type I collagen extracted from tendon of P3H1 null mice
157 r cells exposed to a physiological matrix of type I collagen fibers form elongated collagenolytic inv
159 ng as a fibronectin-independent mechanism of type I collagen fibrillogenesis following adult liver in
162 erminal domains resulted in fragmentation of type I collagen fibrils in a three-dimensional collagen
164 ng and radial nanoindentation, we found that type I collagen fibrils show a pronounced nonlinear beha
165 d by fragmentation and reduced production of type I collagen fibrils that provide strength to skin.
169 train K279a also promoted the degradation of type I collagen, fibrinogen, and fibronectin in a predom
170 cell carcinoma stroma, CCN2-regulated genes type I collagen, fibronectin, and alpha-smooth muscle ac
174 dings, Cyp2j4(-/-) rats show upregulation of type I collagen following unilateral ureter obstruction
175 alpha1alpha2alpha1, alpha2alpha1alpha1) of a type I collagen fragment (the binding region for the von
176 mation and release of C-terminal fragment of type I collagen from cells cultured on bone slices.
179 transgenic system to specifically delete the type I collagen gene across a broad population of hemato
180 r, fibrocytes with confirmed deletion of the type I collagen gene have readily detectable intracellul
186 ls of alpha-smooth muscle actin (alpha-SMA), type I collagen, heat shock protein-47 (HSP-47), fibrone
189 lysis identified five glycosylation sites in type I collagen (i.e. alpha1,2-87, alpha1,2-174, and alp
190 cross-linked carboxyterminal telopeptide of type I collagen (ICTP) and C-terminal crosslinked telope
191 N-terminal peptide], CITP [C-telopeptide for type I collagen], IGFBP7 [insulin-like growth factor-bin
192 inary N-terminal cross-linked telopeptide of type I collagen in a 1999-2002 subset with available dat
193 tate cancer cell adhesion to fibronectin and type I collagen in a FAK-dependent manner, correlating w
196 revealed tissue disorganization and reduced type I collagen in bgn(-/0)fmod(-/-) TMJ subchondral bon
198 l vessel tissues, as well as the presence of type I collagen in the outermost vessel layers, using im
200 sponse demonstrated collagen-rich matrix (by type I collagen), incorporating the device components wi
201 n gene have readily detectable intracellular type I collagen indicating that uptake of collagen from
206 The A1 site (Pro-986) in the alpha1-chain of type I collagen is almost completely 3-hydroxylated in e
207 hese results demonstrate that the A1 site in type I collagen is exclusively 3-hydroxylated by P3H1, a
211 n that alpha2beta1 integrin, the receptor of type I collagen, is the major collagen-binding integrin
212 t inactivation of Fam20C in cells expressing type I collagen led to skeletal defects and hypophosphat
213 othelin-1, troponin I, and C-telopeptide for type I collagen levels, suggesting more severe neurohumo
214 ly 40% of SKPs were found to be derived from type I collagen-lineage cells and acquired multipotency
216 re plated within standard bovine or rat tail type I collagen matrices (2.5 mg/mL), compressed collage
220 eutics incorporated into the self-assembling type I collagen matrix described here can be delivered n
221 in cell expressing actin-eGFP cultured in a type I collagen matrix, the laser was orbited around the
223 ificant increase in the expression of alpha1 type I collagen, matrix metalloprotease-1, and platelet-
226 To elucidate the function of LH3 in bone type I collagen modifications, we used a short hairpin R
227 occurs at the specific molecular loci in the type I collagen molecule and plays critical roles in con
229 imperfecta (OI) is a bone disease caused by type I collagen mutations and characterized by bone frag
230 sociated with preservation of the myocardial type I collagen network as a consequence of the decrease
232 at the nonlinear stiffening of reconstituted type I collagen networks is controlled by the applied st
233 protectin, osteocalcin, and N-telopeptide of type I collagen (NTx) levels were analyzed by ELISA.
235 py targeted at epithelial cell production of type I collagen offers a novel pathway for abrogating th
236 as to investigate the use of self-assembling type I collagen oligomers as an injectable therapeutic d
238 ted adhesion of human platelets to monomeric type I collagen or to the GFOGER peptide caused a time-d
239 important protease responsible for degrading type I collagen, osteopontin, and other bone matrix prot
240 modification, we characterized and compared type I collagen phenotypes produced by Sh clones and two
242 onstrated that inhibition of DDR1 binding to type I collagen, preserving the engagement of the other
243 matic increase in the uncleaved precursor of type I collagen (procollagen I) and a reduction in denti
244 show by inducible genetic fate mapping that type I collagen-producing submesothelial fibroblasts are
245 indicate a TGF-beta-independent mechanism of type I collagen production and suggest connective tissue
254 ive carcinoma cells gain permanent access to type I collagen-rich interstitial tissues, an experiment
255 tures provide a new mechanism of adhesion to type I collagen-rich tissues that does not rely on hydro
257 levels of Sox9, type II collagen, aggrecan, type I collagen, Runx2, type X collagen, ALP, Osterix, a
259 ns that is dominated by polymeric fibrils of type I collagen, serves as the mechanical scaffold on wh
260 bitor, b-AP15, reduced the expression of FN, type I collagen, Smad2/Smad3, and the deposition of coll
264 luble endoglin limits TGFbeta1 signaling and type I collagen synthesis in cardiac fibroblasts and fur
265 ultures to histamine favored cell growth and type I collagen synthesis via the activation of H1 recep
266 uses elongation of fibroblasts, coupled with type I collagen synthesis, which is dependent on the TGF
271 n, metabolism, and pharmacokinetics of a new type I collagen-targeted magnetic resonance (MR) probe,
272 rstitial matrix mainly composed of fibrillar type I collagen, the interactions occurring between lymp
276 olvement in the regulation of MK motility on type I collagen through a mechanism based on the activit
277 l contribution of hematopoietic cell-derived type I collagen to fibrogenesis, we use a double-transge
279 Previously, we showed that ER CRT regulates type I collagen transcript, trafficking, secretion, and
282 Given that ARCN1 deficiency causes defective type I collagen transport, reduction of collagen secreti
283 sential repeating tripeptide sequence of the type I collagen triple helix results in the dominant her
284 ger residue in the repeating sequence of the type I collagen triple helix, lead to the hereditary bon
285 collagen, and type X collagen, but not with type I collagen, type II collagen, or type V collagen.
288 s and dentin depends on the self-assembly of type I collagen via the Gly-X-Y motif, the molecular mec
289 NLO) chiral effects in the amide I region of type I collagen was investigated using sum-frequency gen
290 reduction in total hydrolysis of elastin and type I collagen was measured compared with computational
292 cross-linked carboxyterminal telopeptide of type I collagen were also significantly reduced in the C
293 st levels of carboxy-terminal telopeptide of type I collagen were observed in ZOL (P < 0.05), and sho
294 lasma cross-linked C-terminal telopeptide of type I collagen were reduced by >/= 50% in 57% of evalua
297 rly osteogenic marker genes, ALP, Runx2, and type I collagen, which play a critical role in MSC to os
299 Ovarian cortex biopsies were embedded in type I collagen with or without VEGF111 addition before
300 for unfolding regions of the alpha2 chain of type-I collagen within the context of the microfibril.